These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 29152791)

  • 1. Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities.
    Krueger JG; Brunner PM
    Exp Dermatol; 2018 Feb; 27(2):115-123. PubMed ID: 29152791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.
    Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C
    Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Inflammatory skin march" in atopic dermatitis and psoriasis.
    Furue M; Kadono T
    Inflamm Res; 2017 Oct; 66(10):833-842. PubMed ID: 28620798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.
    Furue M; Tsuji G; Chiba T; Kadono T
    Intern Med; 2017; 56(13):1613-1619. PubMed ID: 28674347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.
    Mellett M; Meier B; Mohanan D; Schairer R; Cheng P; Satoh TK; Kiefer B; Ospelt C; Nobbe S; Thome M; Contassot E; French LE
    J Invest Dermatol; 2018 Sep; 138(9):2010-2023. PubMed ID: 29689250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation.
    An J; Li Z; Dong Y; Ren J; Huo J
    Mol Cell Biochem; 2016 Feb; 413(1-2):87-95. PubMed ID: 26724949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin levels and macrophagic density in periumbilical fat tissue in patients affected by moderate-to-severe psoriasis with metabolic syndrome, before and after etanercept treatment.
    Motolese A; Chiaravalloti V; Cerati M; Oldrini R; Mola F; Passi A
    G Ital Dermatol Venereol; 2017 Aug; 152(4):342-347. PubMed ID: 27284777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function.
    Ippagunta SK; Gangwar R; Finkelstein D; Vogel P; Pelletier S; Gingras S; Redecke V; Häcker H
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6162-E6171. PubMed ID: 27671649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis.
    Varshney P; Saini N
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1795-1803. PubMed ID: 29432814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
    Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
    PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of psoriasis and hypertension: focusing on anti-inflammatory therapies and immunological mechanisms.
    Hu MY; Yang Q; Zheng J
    Clin Exp Dermatol; 2020 Oct; 45(7):836-840. PubMed ID: 32789979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.
    Jin SP; Koh SJ; Yu DA; Kim MW; Yun HT; Lee DH; Yoon HS; Cho S; Park HS
    Exp Dermatol; 2018 Jan; 27(1):43-49. PubMed ID: 28677206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.
    Blauvelt A; Chiricozzi A
    Clin Rev Allergy Immunol; 2018 Dec; 55(3):379-390. PubMed ID: 30109481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
    Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
    J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and Dyslipidemia Synergistically Exacerbate Psoriatic Skin Inflammation.
    Ikeda K; Morizane S; Akagi T; Hiramatsu-Asano S; Tachibana K; Yahagi A; Iseki M; Kaneto H; Wada J; Ishihara K; Morita Y; Mukai T
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
    Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
    J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
    Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
    Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.